137798 <common-name>BMS-813160</common-name> <description>BMS-813160 is an organic compound with the formula C25H40N8O2 and an average molecular weight of 484.65 g/mol. BMS-813160 belongs to the amino acids, peptides, and analogues, a subclass of carboxylic acids and derivatives within the organic compounds. This compound acts upon two recorded protein targets, serving as a modulator of C-C chemokine receptor type 2 (CCR2) and C-C chemokine receptor type 5 (CCR5).</description> <cas>1286279-29-5</cas> <pubchem-id>51039119</pubchem-id> <chemical-formula>C25H40N8O2</chemical-formula> <weight>484.6</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-04-14T20:41:28Z</created-at> <updated-at type="dateTime">2026-08-22T05:32:43Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id>DB16240</drugbank-id> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@H](NC2=NC=NC3=CC(=NN23)C(C)(C)C)C1=O)NC(C)(C)C</moldb-smiles> <moldb-formula>C25H40N8O2</moldb-formula> <moldb-inchi>InChI=1S/C25H40N8O2/c1-15(34)28-18-12-16(30-25(5,6)7)8-9-19(18)32-11-10-17(22(32)35)29-23-27-14-26-21-13-20(24(2,3)4)31-33(21)23/h13-14,16-19,30H,8-12H2,1-7H3,(H,28,34)(H,26,27,29)/t16-,17+,18-,19+/m1/s1</moldb-inchi> <moldb-inchikey>CMVHFGNTABZQJU-HCXYKTFWSA-N</moldb-inchikey> <moldb-average-mass type="decimal">484.649</moldb-average-mass> <moldb-mono-mass type="decimal">484.32742256</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>1.63</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM133691</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>N-[(1R,2S,5R)-5-(tert-butylamino)-2-[(3S)-3-({7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-yl}amino)-2-oxopyrrolidin-1-yl]cyclohexyl]acetamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organic acids and derivatives</superklass> <klass>Carboxylic acids and derivatives</klass> <subklass>Amino acids, peptides, and analogues</subklass> <paper-count type="integer">297</paper-count> <sync-id>CED0013311</sync-id> <structure-inchikey>CMVHFGNTABZQJU-HCXYKTFWSA-N</structure-inchikey> <structure-fingerprint>4400000000020000000800000002000000000040000000000008000001004000000000000000021000000000000102110800008000000000000000000c000000000000000000000000000100000000040200000000804000000000000000000000000000100100200000100001000000001000201000000000000008000005002000000400000000000000000000000804000000000000000000000000000000008000000040010000000000800081000000000000820000080000000000000000000000000048800000000200000100000004000008000100000000000000000002000000000000000400000000004800000000c0000000000800000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAjAAAAJgAAAIABBgBgAAAAAQMGACgAAAAD BAgAKAAAAAMCBwBoAAAAAwIBBiA0AAAAAgEEBgBgAAAAAgIGIDQAAAABAQQG AGAAAAACAgYAYAAAAAICBiA0AAAAAgEEBwAoAAAAAwMGAGAAAAACAgYAYAAA AAICBiA0AAAAAgEEBwBoAAAAAwIBBkAoAAAAAwQHQCgAAAADAwZAaAAAAAMD AQdAKAAAAAMDBkAoAAAAAwQGQGgAAAADAwEGQCgAAAADBAdAKAAAAAMDB0Ao AAAAAwMGACAAAAAEBgBgAAAAAQMGAGAAAAABAwYAYAAAAAEDBgAoAAAAAwQI ACgAAAADAgcAYAAAAAIBBgAgAAAABAYAYAAAAAEDBgBgAAAAAQMGAGAAAAAB AwsAAQABAigCAQMgAwQABAUABQYABgcABwgACAkACQoACgsACwwADA0ADQ4A Dg8gDxBoDBARaAwREmgMEhNoDBMUaAwUFWgMFRZoDBYXaAwVGAAYGQAYGgAY GwANHAAcHSgCBh4AHh8AHyAAHyEAHyIACQQAHAogFw9oDBcTaAxCBAAAAAYE CQgHBgUFCwocDQwGEBESExcPBRQTFxYVFwQAAAAAAAAAFg== </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T04:50:36Z</structure-indexed-at> </compound>